Anne Therese Tveter

ORCID: 0000-0003-1701-9835
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Musculoskeletal pain and rehabilitation
  • Osteoarthritis Treatment and Mechanisms
  • Orthopedic Surgery and Rehabilitation
  • SARS-CoV-2 and COVID-19 Research
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Workplace Health and Well-being
  • COVID-19 Clinical Research Studies
  • Cerebral Palsy and Movement Disorders
  • Nuclear physics research studies
  • Mobile Health and mHealth Applications
  • Autoimmune and Inflammatory Disorders Research
  • Musculoskeletal Disorders and Rehabilitation
  • Telemedicine and Telehealth Implementation
  • Delphi Technique in Research
  • Shoulder Injury and Treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Total Knee Arthroplasty Outcomes
  • Peripheral Neuropathies and Disorders
  • Pregnancy-related medical research
  • Spondyloarthritis Studies and Treatments
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Rheumatoid Arthritis Research and Therapies
  • Medical and Biological Sciences
  • Cancer Immunotherapy and Biomarkers
  • Nuclear Physics and Applications

Diakonhjemmet Hospital
2018-2025

OsloMet – Oslo Metropolitan University
2015-2025

Norwegian Directorate of Health
2025

Metropolitan University
2023-2024

Institute for Rheumatic Diseases (Japan)
2024

Center for Rheumatology
2022

Oslo University Hospital
2008-2017

University of Oslo
1964-2016

Institutt for Eksperimentell Medisinsk Forskning
2015

Wright-Patterson Air Force Base
1971-1972

Hip and knee osteoarthritis (OA) are increasingly common with a significant impact on individuals society. Non-pharmacological treatments considered essential to reduce pain improve function quality of life. EULAR recommendations for the non-pharmacological core management hip OA were published in 2013. Given large number subsequent studies, an update is needed.

10.1136/ard-2023-225041 article EN cc-by-nc Annals of the Rheumatic Diseases 2024-01-11

Objective Immunogenicity and safety following receipt of the standard SARS–CoV‐2 vaccination regimen in patients with immune‐mediated inflammatory diseases (IMIDs) are poorly characterized, data after third vaccine dose lacking. The aim study was to evaluate serologic responses adverse events 2‐dose a IMID receiving immunosuppressive therapy. Methods Adult therapy for rheumatoid arthritis, spondyloarthritis, psoriatic Crohn's disease, or ulcerative colitis, as well healthy adult controls,...

10.1002/art.42153 article EN cc-by-nc-nd Arthritis & Rheumatology 2022-05-04

Objectives To assess the effect of high-intensity interval training (HIIT) delivered in physiotherapy primary care on outcome cardiorespiratory fitness (CRF) patients with inflammatory arthritis (IA). Additionally, to explore effects HIIT secondary outcomes, including cardiovascular disease (CVD) risk factors and activity. Methods Single-blinded randomised controlled trial 60 randomly assigned either a control group receiving usual or an exercise 12 weeks individualised at 90%–95% peak heart...

10.1136/rmdopen-2023-003440 article EN cc-by-nc RMD Open 2024-01-01

Low back pain (LBP) and pelvic girdle (PGP) are commonly reported during pregnancy known to affect pregnant women's well-being. Still, these conditions often considered be a normal part of pregnancy. This study assesses the prevalence severity LBP and/or PGP among Nepalese women, as well exploring factors associated with PGP.A cross-sectional successive recruitment women was conducted at two district hospitals in Nepal from May 2016 2017. The data collected using self-reported...

10.1186/s12884-019-2398-0 article EN cc-by BMC Pregnancy and Childbirth 2019-07-15

Objectives Humoral vaccine responses to SARS-CoV-2 vaccines are impaired and short lasting in patients with immune-mediated inflammatory diseases (IMID) following two doses. To protect these vulnerable against severe COVID-19 disease, a three-dose primary vaccination strategy has been implemented many countries. The aim of this study was evaluate humoral response safety three doses IMID. Methods Patients IMID on immunosuppressive therapy healthy controls receiving two-dose vaccination,...

10.1136/rmdopen-2022-002417 article EN cc-by-nc RMD Open 2022-11-01

Abstract Objective This protocol paper describes the rationale and design of a randomised controlled trial (RCT) that aims to evaluate (cost-)effectiveness 12 week e-self-management intervention (Happy Hands app) in people with hand osteoarthritis (HOA). Methods In this multicentre RCT, 376 HOA will be recruited from all four health regions Norway. Consenting participants randomly allocated either control group receiving usual care or an Happy app addition care. Primary outcome measured at...

10.1007/s00296-025-05787-6 article EN cc-by Rheumatology International 2025-01-16

People with hand osteoarthritis (OA) often have poor access to recommended treatments. To enhance care quality, quality indicators (QIs) based on clinical recommendations are essential. Current QI sets, like the Osteoarthritis Quality Indicator Questionnaire (OA-QI v.2), primarily address hip- and knee OA, not OA. adapt OA-QI v.2 for assessing patient-reported of OA care. We used v.2. set as a starting point adapted it reflect A literature search was performed identify potential QIs...

10.1016/j.ocarto.2025.100578 article EN cc-by Osteoarthritis and Cartilage Open 2025-02-05

Background Axial spondyloarthritis (axSpA) is a chronic inflammatory joint disease affecting the spine and sacroiliac joints, requiring frequent, lifelong monitoring treatment. This involves regular symptom monitoring, assessing medication tolerance side effects, prompt therapy adjustments. Typically, patients with axSpA attend prescheduled hospital visits, but once stable has been attained, these seldom align periods of high activity. Remote patient-initiated care offer flexible,...

10.2196/63569 article EN cc-by Journal of Medical Internet Research 2025-02-20

Abstract Purpose Given the lack of robust prognostic models for early identification individuals at risk work disability, this study aimed to develop and externally validate three prolonged absence among on sick leave due musculoskeletal disorders. Methods We developed multivariable logistic regression using data from 934 4–12 weeks disorders, recruited through Norwegian Labour Welfare Administration. The predicted outcomes: (1) > 90 consecutive days, (2) 180 (3) any new or increased...

10.1007/s00420-025-02129-8 article EN cc-by International Archives of Occupational and Environmental Health 2025-04-08

A cross-sectional study with a test-retest design.To assess measurement properties of the physical fitness questionnaire, 6-minute walk test, stair hand-grip 30-second sit-to-stand and fingertip-to-floor test in patients various musculoskeletal conditions (MSCs).Patients suffering from MSCs tend to be more deconditioned less physically active than healthy people. Physiotherapists should, therefore, focus on health-related addition their patients' specific offer optimal treatment. To enable...

10.2519/jospt.2014.5042 article EN Journal of Orthopaedic and Sports Physical Therapy 2014-01-23

Abstract Background To tailor physical activity treatment programs for patients with osteoarthritis, clinicians need valid and feasible measurement tools to evaluate habitual activity. The widely used International Physical Activity Questionnaire-Short Form (IPAQ-SF) is not previously validated in osteoarthritis. Purpose assess the concurrent criterion validity of IPAQ-SF using an accelerometer as a criterion-method. Method Patients osteoarthritis ( n = 115) were recruited at Division...

10.1186/s12891-021-04069-z article EN cc-by BMC Musculoskeletal Disorders 2021-02-27

Objectives The objective was to identify modifiable prognostic factors of high societal costs among people on sick leave due musculoskeletal disorders, and related separately healthcare utilisation productivity loss. Design A prospective cohort study with a 1-year follow-up. Participants setting total 549 participants (aged 18–67 years) (≥ 4 weeks) disorders in Norway were included. Outcome measures method primary outcome aggregated for 1 year follow-up dichotomised as or low, defined by the...

10.1136/bmjopen-2023-080567 article EN cc-by-nc-nd BMJ Open 2024-03-01

Objectives To assess incidence, severity and predictors of COVID-19, including protective post-vaccination levels antibodies to the receptor-binding domain SARS-CoV-2 spike protein (anti-RBD), informing further vaccine strategies for patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressive medication. Methods IMIDs immunosuppressives healthy controls (HC) receiving vaccines were included in this prospective observational study. COVID-19 outcome registered anti-RBD...

10.1136/rmdopen-2023-003545 article EN cc-by-nc RMD Open 2024-04-01
Coming Soon ...